1. CR4056, a first-in-class imidazoline-2 receptor ligand analgesic, in pain from knee osteoarthritis phenotypes: a randomized, placebo-controlled, double-blind, phase iia clinical trial. (April 2018) Authors: Rovati, L.; Probert, N.J.; Blicharski, T.; Brambilla, N.; Vitalini, C.; Girolami, F.; Giacovelli, G.; D'Amato, M. Journal: Osteoarthritis and cartilage Issue: Volume 26(2018)Supplement 1 Page Start: S308 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗